Journal
PANCREATOLOGY
Volume 17, Issue 1, Pages 7-12Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.pan.2016.12.010
Keywords
Chemoresistance; Hypoxia; Tumor initiating cells; Metabolism
Categories
Funding
- NIH [R01-CA170946, CA124723, R01-CA184274]
Ask authors/readers for more resources
Every year, nearly 300,000 people are diagnosed with pancreatic cancer worldwide, and an equivalent number succumb to this disease. One of the major challenges of pancreatic cancer that contributes to its poor survival rates is the development of resistance to the standard chemotherapy. Heterogeneity of the tumor, the dense fibroblastic stroma, and the aggressive biology of the tumor all contribute to the chemoresistant phenotype. In addition, the acellular components of the tumor microenvironment like hypoxia, stress pathways in the stromal cells, and the cytokines that are secreted by the immune cells, have a definitive role in orchestrating the chemoresistant property of the tumor. In this review, we systematically focus on the role played by the different microenvironmental components in determining chemoresistance of pancreatic tumors. (C) 2017 IAP and EPC. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available